Laboratory of Mendelian Diabetes, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome, Italy.
Diabetologia. 2011 Jul;54(7):1693-701. doi: 10.1007/s00125-011-2094-8. Epub 2011 Mar 10.
AIMS/HYPOTHESIS: The aim of this study was to investigate the genetic aetiology of permanent diabetes mellitus with onset in the first 12 months of age.
We studied 46 probands with permanent, insulin-requiring diabetes with onset within the first 6 months of life (permanent neonatal diabetes mellitus [PNDM]/monogenic diabetes of infancy [MDI]) (group 1) and eight participants with diabetes diagnosed between 7 and 12 months of age (group 2). KCNJ11, INS and ABCC8 genes were sequentially sequenced in all patients. For those who were negative in the initial screening, we examined ERN1, CHGA, CHGB and NKX6-1 genes and, in selected probands, CACNA1C, GCK, FOXP3, NEUROG3 and CDK4. The incidence rate for PNDM/MDI was calculated using a database of Italian patients collected from 1995 to 2009.
In group 1 we found mutations in KCNJ11, INS and ABCC8 genes in 23 (50%), 9 (19.5%) and 4 (8.6%) patients respectively, and a single homozygous mutation in GCK (2.1%). In group 2, we identified one incidence of a KCNJ11 mutation. No genetic defects were detected in other loci. The incidence rate of PNDM/MDI in Italy is estimated to be 1:210,287.
CONCLUSIONS/INTERPRETATION: Genetic mutations were identified in ~75% of non-consanguineous probands with PNDM/MDI, using sequential screening of KCNJ11, INS and ABCC8 genes in infants diagnosed within the first 6 months of age. This percentage decreased to 12% in those with diabetes diagnosed between 7 and 12 months. Patients belonging to the latter group may either carry mutations in genes different from those commonly found in PNDM/MDI or have developed an early-onset form of autoimmune diabetes.
目的/假设:本研究旨在探讨 12 个月以内发病的永久性糖尿病的遗传病因。
我们研究了 46 例在生命最初 6 个月内发病的需胰岛素治疗的永久性糖尿病(永久性新生儿糖尿病[PNDM]/婴儿期单基因糖尿病[MDI])(第 1 组)的患者,以及 8 例在 7 至 12 个月龄间发病的患者(第 2 组)。所有患者均依次对 KCNJ11、INS 和 ABCC8 基因进行了测序。在初始筛选中为阴性的患者,我们检查了 ERN1、CHGA、CHGB 和 NKX6-1 基因,在部分患者中检查了 CACNA1C、GCK、FOXP3、NEUROG3 和 CDK4 基因。使用 1995 年至 2009 年期间从意大利患者数据库中收集的数据计算了 PNDM/MDI 的发病率。
第 1 组中,我们在 23 例(50%)、9 例(19.5%)和 4 例(8.6%)患者中分别发现了 KCNJ11、INS 和 ABCC8 基因突变,以及 1 例 GCK 基因纯合突变(2.1%)。第 2 组中发现了 1 例 KCNJ11 基因突变。在其他基因座未检测到遗传缺陷。意大利 PNDM/MDI 的发病率估计为 1:210287。
结论/解释:通过对出生后 6 个月内确诊的患儿进行 KCNJ11、INS 和 ABCC8 基因的顺序筛查,在~75%的非近亲婚配的 PNDM/MDI 患儿中发现了基因突变。在 7 至 12 个月龄发病的患儿中,这一比例下降至 12%。后者可能携带 PNDM/MDI 中常见基因突变之外的基因突变,或者患有早发型自身免疫性糖尿病。